生物医药企业Alamar纳斯达克上市：市值14亿美元年亏2982万美元

雷递网04-19

雷递网雷建平 4月19日精准蛋白质组学领域Alamar Biosciences（股票代码为“ALMR”）日前在美国纳斯达克上市。Alamar Biosciences发行价为17美元，发行1125万股，募资总额为1.91亿美元。Alamar Biosciences首日开盘价为22.6美元，较发行价上涨32.9%；收盘价为22美元，较发行价上涨29%；以收盘价计算，公司市值为14.28亿美元。年营收...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2628665157?lang=zh_CN&edition=full","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260419/6391220993276710514400681.jpeg","is_english":false,"pubTime":"2026-04-19 15:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2628665157","market":"sh","top_or_hot":-1,"title":"生物医药企业Alamar纳斯达克上市：市值14亿美元 年亏2982万美元","media":"雷递网","content":"<div>\n<p>雷递网 雷建平 4月19日精准蛋白质组学领域Alamar Biosciences（股票代码为“ALMR”）日前在美国纳斯达克上市。Alamar Biosciences发行价为17美元，发行1125万股，募资总额为1.91亿美元。Alamar Biosciences首日开盘价为22.6美元，较发行价上涨32.9%；收盘价为22美元，较发行价上涨29%；以收盘价计算，公司市值为14.28亿美元。年营收...</p>\n\n<a href=\"https://www.leinews.com/n33339/detail.html\">网页链接</a>\n\n</div>\n","source":"leinews_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>生物医药企业Alamar纳斯达克上市：市值14亿美元 年亏2982万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n生物医药企业Alamar纳斯达克上市：市值14亿美元 年亏2982万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-19 15:39 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.leinews.com/n33339/detail.html><strong>雷递网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>雷递网 雷建平 4月19日精准蛋白质组学领域Alamar Biosciences（股票代码为“ALMR”）日前在美国纳斯达克上市。Alamar Biosciences发行价为17美元，发行1125万股，募资总额为1.91亿美元。Alamar Biosciences首日开盘价为22.6美元，较发行价上涨32.9%；收盘价为22美元，较发行价上涨29%；以收盘价计算，公司市值为14.28亿美元。年营收...</p>\n\n<a href=\"https://www.leinews.com/n33339/detail.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GPIQ","symbol_name":"GOLDMAN SACHS NASDAQ 100 CORE PREMIUM INCOME ETF","start_time":0,"source_url":"https://www.leinews.com/n33339/detail.html","article_id":"2628665157","we_media_id":null,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260419/6391220993276710514400681.jpeg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2628665157","pubTimestamp":1776584368,"columns":[],"sourceInfo":{"source_id":"leinews_highlight","name":"雷帝触网"},"weMediaInfo":null,"summary":"精准蛋白质组学领域Alamar Biosciences（股票代码为“ALMR”）日前在美国纳斯达克上市。","collect":0,"end_time":0,"defaultTopTitle":"leinews.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"GPIQ":"GOLDMAN SACHS NASDAQ 100 CORE PREMIUM INCOME ETF","BK1147":"投资银行业与经纪业","QQQ":"纳指100ETF","QLD":"2倍做多纳斯达克100指数ETF-ProShares","ONEQ":"Fidelity NASDAQ Composite Index ETF","IYW":"美国科技ETF-iShares","TQQQ":"纳指三倍做多ETF","QQQA":"ProShares Nasdaq-100 Dorsey Wright Momentum ETF","TQQY":"GraniteShares YieldBOOST QQQ ETF","QID":"两倍做空纳斯达克指数ETF-ProShares","SQQQ":"纳指三倍做空ETF","QQQE":"Direxion NASDAQ-100 Equal Weighted Index Shares","BK4588":"碎股","QQQY":"Defiance Nasdaq 100 Enhanced Options & 0DTE Income ETF","PSQ":"做空纳斯达克100指数ETF-ProShares","QYLG":"Nasdaq 100 Covered Call & Growth ETF","JEPQ":"JPMorgan Nasdaq Equity Premium Income ETF","NVIW.SI":"NVDA 3xLongSG261006","BK4585":"ETF&股票定投概念","BK4007":"制药","QDTE":"Roundhill N-100 0DTE Covered Call Strategy ETF","QQQJ":"Invesco NASDAQ Next Gen 100 ETF","BK4581":"高盛持仓","QQQM":"NASDAQ100指数ETF-Invesco","FTEC":"Fidelity MSCI Information Techno","ALMR":"Alamar Biosciences, Inc."},"translate_title":"Biopharmaceutical company Alamar listed on Nasdaq: market value of $1.4 billion, annual loss of $29.82 million","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/53c4813ce35dabcd7c07fd73dc1e879d","symbols_score_info":{"PSQ":0.6,"IYW":0.6,"FTEC":0.6,"QYLG":0.6,"QQQE":0.6,"QQQA":0.6,"QQQY":0.6,"GPIQ":0.6,"NVIW.SI":0.6,"ALMR":1.96,"TQQY":0.6,"TQQQ":0.6,"QID":0.6,"ONEQ":0.6,"MNQmain":0.6,"QDTE":0.6,"QQQ":0.6,"JEPQ":0.6,"QLD":0.6,"NQmain":0.6,"QQQM":0.6,"QQQJ":0.6,"SQQQ":0.6},"content_text":"雷递网 雷建平 4月19日精准蛋白质组学领域Alamar Biosciences（股票代码为“ALMR”）日前在美国纳斯达克上市。Alamar Biosciences发行价为17美元，发行1125万股，募资总额为1.91亿美元。Alamar Biosciences首日开盘价为22.6美元，较发行价上涨32.9%；收盘价为22美元，较发行价上涨29%；以收盘价计算，公司市值为14.28亿美元。年营收7421万美元 净亏损2982万美元据介绍，Alamar Biosciences成立于2018年，是一家商业阶段蛋白质组学公司，建立了蛋白质检测和分析的黄金标准。Alamar Biosciences的NULISA技术旨在解决现有蛋白质组学工具局限性，通过检测血液等非侵入性生物液体中极低浓度的蛋白质生物标志物，具有超高灵敏度、高特异性、灵活多路复用、宽动态范围和无缝自动化。Alamar Biosciences将这种特征组合称为“精确蛋白质组学”，并认为它填补了先进蛋白质组学领域的一个关键空白，使研究人员能建立多重蛋白质生物标志物的增量变化与健康、疾病和药物治疗中具有临床意义的差异之间的关系。招股书显示，Alamar Biosciences在2024年、2025年营收分别为2514万美元、7421万美元；毛利分别为861万美元、4171万美元。Alamar Biosciences在2024年、2025年运营亏损分别为4957万美元、3133万美元；净亏损分别为4707万美元、2982万美元。Alamar Biosciences创始人、CEO为Yuling Luo, Ph.D.，是一个华裔。Alamar Bioscience持股比例超过5%的股东包括启明创投、Illumina Innovation、Sherpa Healthcare Partners、Sands Capital Life Sciences Pulse Fund II。——————————————————雷递由媒体人雷建平创办，若转载请写明来源。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.4","shortVersion":"4.42.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2628665157","isCrawlerRequest":true}

生物医药企业Alamar纳斯达克上市：市值14亿美元 年亏2982万美元

精彩评论

生物医药企业Alamar纳斯达克上市：市值14亿美元年亏2982万美元